TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled Trial.

Rubeshan Perumal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.